Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients. (Q35211301)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients. |
scientific article |
Statements
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients (English)
A Llombart-Cussac
M Bellet
V Guillem-Porta
N Enas
K Krejcy
E Carrasco
L Kayitalire
M Kuta
P Vodvarka
P Kerbrat
M Namer
1 September 2003